Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurement - Summary of Warrant and Option Liabilities (Details)

v3.10.0.1
Fair Value Measurement - Summary of Warrant and Option Liabilities (Details)
9 Months Ended
Dec. 31, 2018
USD ($)
Fair market value of options to be issued to NitricGen $ 295,000
Warrant Liability [Member]  
Balance, beginning 5,677,934
Fair market value of options to be issued to NitricGen 295,000
Reclassification of warrant liability to stockholders' equity upon adoption of ASU-2017-11 (5,677,934)
Balance, ending $ 295,000